-
Legal ruling confirms that ‘routine’ discoveries can be patented
europeanpharmaceuticalreview
April 30, 2019
Legal ruling confirms that ‘routine’ discoveries can be patented.
-
£54 million funding to transform health through data science
europeanpharmaceuticalreview
April 29, 2019
Health Data Research UK is awarding £30 million funding to six sites across the UK to address challenging healthcare issues through the use of data science…
-
UK regulatory approval for SCIB1 phase II advanced melanoma trial
pharmatimes
April 28, 2019
Scancell Holdings has announced that it has received UK regulatory approval to start its Phase II trial assessing SCIB1 in patients with metastatic melanoma.
-
The Creative Engagement Group ‘strengthens’ offerings, launches Axiom in Europe
pharmatimes
April 16, 2019
The Creative Engagement Group (TCEG) has announced the launch of its new medical training……
-
Blood pressure and heart medication recalled by MHRA in UK
europeanpharmaceuticalreview
April 16, 2019
The MHRA have announced another sartan-containing drug product over fears that it is contaminated with the carcinogen N‑nitrosodiethylamine…
-
Epilepsy Society calls for review of UK supply chain following
pharmafile
April 11, 2019
The Epilepsy Society has drawn attention to the “steep rise” in UK patients who are encountering difficulty in accessing seizure medication.
-
GSK named one of ‘top companies’ to work for in UK
europeanpharmaceuticalreview
April 10, 2019
Some of the key findings show that job seekers are drawn to companies with long histories and large organisations with over 50,000 employees…
-
UK prioritises rare diseases in genomic medicine strategy
pharmaceutical-technology
February 28, 2019
In preparation for Rare Disease Day on 28 March, the UK Government has announced a National Genomic Healthcare Strategy that specifically focuses on providing predictive, personalised health services to people with rare diseases....
-
No-deal Brexit could put UK patients at risk of fake medicines
pharmaceutical-technology
February 13, 2019
The Association of the British Pharmaceutical Industry (ABPI), a trade group representing drugmakers in the UK, has warned that patients in the country could be at risk of counterfeit medicines in the event of a no-deal Brexit....
-
UK biotech funding increased by 85 percent in 2018
europeanpharmaceuticalreview
January 29, 2019
UK-based biotech companies raised £2.2billion from investors in 2018, an increase of 85 percent from the year before, a report has found…